Open Label RCT for Chronic Severe AR : Entresto vs. CCB/ARB

Clinical trial NCT05212597 · UNKNOWN

Trial details

NCT number: NCT05212597
Sponsor: Samsung Medical Center
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Aortic Valve Insufficiency

Start date: 2022-01-12
Primary completion: 2023-12-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.